
Alps Alpine Adopts Silvaco's Jivaro Pro to Accelerate SPICE Post-Layout Simulation
Key Highlights
SANTA CLARA, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. ('Silvaco') (NASDAQ: SVCO), a leading provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today announced that Alps Alpine Co., Ltd., an electronics company that manufactures and markets various sensors, electronic components, audio equipment, and in-car navigation systems in the automotive and consumer markets, has adopted Jivaro Pro™, a best-in-class solution for the development and verification of integrated circuits (ICs), including sensor conditioning ICs that support sensor products. Jivaro Pro is a unique stand-alone tool that dramatically speeds up SPICE simulations, accelerating productivity, enabling increased verification coverage and reducing design schedule risk.
Adopted by leading semiconductor companies worldwide for technologies from 180nm down to 3nm, Jivaro Pro accelerates SPICE simulation speeds by up to 15x by significantly reducing post-extraction netlists while maintaining high accuracy. Compared to embedded generic reduction in extractors or simulators, Jivaro Pro is unique in the degree and flexibility of parasitic reduction strategies it offers to designers. These benefits minimize the cost of simulation while ensuring timely project completion.
With the addition of Jivaro Pro to its development flow, Alps Alpine Co., Ltd. aims to accelerate the development of high-precision sensor products, bringing them to market faster.
'The introduction of Jivaro Pro is consistently reducing post-layout SPICE simulation run times while maintaining accuracy, with at least a 5X improvement observed at the 40nm and 55nm nodes. We expect to see a substantial improvement in engineering productivity as post-layout simulation times have been significantly reduced for many blocks, accelerating our overall timeline', said Yasuyuki Hattori, Senior Manager of IC Engineering Dept. Engineering Headquarters at Alps Alpine Co., Ltd.
Jivaro Pro seamlessly fits into existing flows and is simulation and extraction tool agnostic, providing designers with flexibility and usability. With a rich set of features, Jivaro Pro offers engineers an ideal solution for a broad set of designs and challenges.
'Developing the most advanced and sophisticated integrated circuits requires the most advanced and sophisticated tools,' said Dan Fitzpatrick, Vice President and general manager of the EDA business unit at Silvaco. 'Jivaro Pro is a key component in Silvaco's Analog Custom Design tool portfolio offering designers the tools needed to exceed their design goals while minimizing simulation costs and reducing design-cycle risk.'
About Silvaco Group, Inc.
Silvaco is a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation. Silvaco's solutions are used for semiconductor and photonics processes, devices, and systems development across display, power devices, automotive, memory, high performance compute, foundries, photonics, internet of things, and 5G/6G mobile markets for complex SoC design. Silvaco is headquartered in Santa Clara, California, and has a global presence with offices located in North America, Europe, Brazil, China, Japan, Korea, Singapore, and Taiwan. Learn more at silvaco.com.
Contacts
Media Relations:
Tiffany Behany, [email protected]
Investor Relations:
Greg McNiff, [email protected]
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
June 14: Oxbow Fire Department Classic Car Show
Oxbow Fire Department 9th Annual & Dave Benson 3rd Annual Classic Car Show will be held on Saturday, June 14, from 11 a.m. to 3 p.m. at Oxbow Park on Main Street No fee for cars, 'If it is old or different, bring it down! We will be proud to show it!' Awards will be given for different categories of cars and tractors. There will also be live music. Food, including hot dogs, hamburgers and sausages, will be sold and chicken BBQ will start being served at noon. All proceeds benefit the Oxbow Fire Department. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
42 minutes ago
- Yahoo
Homewi$e: How student loans affect homeowners, potential buyers?
DES MOINES, Iowa — On this week's episode of Homewi$e Amanda Krenz and mortgage expert Tyler Osby discuss how student loan repayment can affect potential homebuyers and current homeowners. Past Episodes: Homewi$e: How student loans affect homeowners, potential buyers? Homewi$e: What you need to know about closing on a home Homewi$e: Who pays the realtors? Homewi$e: Credit check can trigger series of events, what to know Homewi$e: What is a gift of equity, what can it do for you? Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Business Wire
an hour ago
- Business Wire
Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. ('Samsung Bioepis') announced today that the company has entered into a license, development and commercialization agreement with NIPRO Corporation ('NIPRO') for multiple biosimilar candidates including SB17, ustekinumab biosimilar candidate, in Japan. 'This partnership marks an important step towards expanding our footprint in Japan. Biosimilars have a great potential to bring cost savings and widen access to treatments for healthcare systems, providers, and patients in Japan." Share Under the terms of the agreement, Samsung Bioepis will be responsible for the development, manufacture and supply of the medicines, while NIPRO will be responsible for commercialization of the medicines in Japan. 'This partnership marks an important step towards expanding our footprint in Japan. Biosimilars have a great potential to bring cost savings and widen access to treatments for healthcare systems, providers, and patients in Japan. We look forward to collaborating with NIPRO, a company renowned for its high-quality medical devices and healthcare solutions, to accelerate access to treatments in the Japanese market,' said Kyung-Ah Kim, President and Chief Executive Officer of Samsung Bioepis. 'We will continue to advance our development platform and innovate access to treatments for healthcare systems, payers, physicians, and patients around the world.' About Samsung Bioepis Co., Ltd. Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology, hematology, nephrology, and endocrinology. For more information, please visit: and follow us on social media – LinkedIn, X.